摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-thiol-1,2-dicarba-closo-dodecaborane | 17526-07-7

中文名称
——
中文别名
——
英文名称
1-thiol-1,2-dicarba-closo-dodecaborane
英文别名
1-mercapto-1,2-dicarba-closo-dodecaborane;1-mercapto-1,2-carborane;1-mercapto-o-carborane;1-(SH)-1,2-C2B10H11;1-thiol-o-carborane;1-thio-o-carborane
1-thiol-1,2-dicarba-closo-dodecaborane化学式
CAS
17526-07-7
化学式
C2H12B10S
mdl
——
分子量
176.293
InChiKey
CLEZWMJIMPGPGP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

SDS

SDS:cb8a57bceea9d131dda35770fb1fad71
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    单硫代碳硼烷(HS)C 2 B 10 H 11的热异构化和9-(HS)-1,2-C 2 B 10 H 11和9-(HS)-1,7-C 2的固态研究B 10高11
    摘要:
    在300〜500℃,三C-硫醇化闭合碳-dicarbadodecaborane异构体1-(HS)-1,2--C 2乙10 ħ 11(1- ø),1-(HS)-1,7--C 2乙10 H 11(1- m)和1-(HS)-1,12-C 2 B 10 H 11(1- p)和两个B-硫代异构体9-(HS)-1,7-C 2 B 10 H 11(9- m)和9-(HS)-1,2-C 2 B 10 H 11(9- o)示出了两种类型的反应组成:首先,从除去SH基团的闭合碳-dicarbadodecaborane骨架,和第二,骨骼异构化从邻位到间位到第导致新的异构体。还观察到以前从未报道过的从碳到硼的SH跳跃。讨论了巯基对骨骼重排的影响。异构化产物是基于其计算获得的偶极矩与其气相色谱保留时间的相关性进行分配的。单硫醇化物质分子能的计算结果表明,所计算的相对稳定性与异构化产物的发生率和相对量之间具有良好的一致性。两种起始的B-硫醇化异构体9
    DOI:
    10.1016/j.jorganchem.2015.06.020
  • 作为产物:
    描述:
    1,2-dicarba-closo-dodecaborane(12) 、 sulfur 在 正丁基锂 作用下, 以 乙二醇二甲醚 为溶剂, 以87 %的产率得到1-thiol-1,2-dicarba-closo-dodecaborane
    参考文献:
    名称:
    Introducing Carborane Clusters into Crystalline Frameworks via Thiol‐Yne Click Chemistry for Energetic Materials
    摘要:
    Crystalline frameworks represent a cutting‐edge frontier in material science, and recently, there has been a surge of interest in energetic crystalline frameworks. However, the well‐established porosity often leads to diminished output energy, necessitating a novel approach for performance enhancement. Thiol‐yne coupling, a versatile metal‐free click reaction, has been underutilized in crystalline frameworks. As a proof of concept, we herein demonstrate the potential of this approach by introducing the energy‐rich, size‐matched, and reductive 1,2‐dicarbadodecaborane‐1‐thiol (CB−SH) into an acetylene‐functionalized framework, Zn(AIm)2, via thiol‐yne click reaction. This innovative decoration strategy resulted in a remarkable 46.6 % increase in energy density, a six‐fold reduction in ignition delay time (4 ms) with red fuming nitric acid as the oxidizer, and impressive enhancement of stability. Density functional theory calculations were employed to elucidate the mechanism by which CB−SH promotes hypergolic ignition. The thiol‐yne click modification strategy presented here permits engineering of crystalline frameworks for the design of advanced energetic materials.
    DOI:
    10.1002/anie.202402363
点击查看最新优质反应信息

文献信息

  • [EN] CARBORANE HYDROXAMIC ACID MATRIX METALLOPROTEINASE AGENTS FOR BORON NEUTRON CAPTURE THERAPY<br/>[FR] AGENTS DE MÉTALLOPROTÉINASE MATRICIELLE D'ACIDE HYDROXAMIQUE CARBORANE POUR UNE THÉRAPIE DE CAPTURE DE NEUTRONS DE BORE
    申请人:UNIV LOYOLA CHICAGO
    公开号:WO2020252439A1
    公开(公告)日:2020-12-17
    Disclosed herein are novel carborane hydroxamic acid matrix metalloproteinase ("MMP") agents bearing borane-containing moieties and methods for their use in treating or preventing a disease, such as cancer and rheumatoid arthritis. In particular, disclosed herein are compounds of Formula (I) and (II) and pharmaceutically acceptable salt thereof: wherein the substituents are as described.
    本发明公开了新颖的碳硼烷酸基质蛋白酶("MMP")抑制剂,其含有硼烷基团,并公开了利用这些抑制剂治疗或预防疾病(如癌症和类风湿性关节炎)的方法。特别地,本发明公开了式(I)和(II)的化合物及其药学上可接受的盐,其中取代基如说明书中所述。
  • Synthesis and Characterization of the First Cyclic Monothioether Derivative of 1,2-<i>o</i>-Carborane and Its Reactivity toward Phosphine Transition Metal Complexes
    作者:Clara Viñas、M. Rosa Cirera、Francesc Teixidor、Raikko Kivekäs、Reijo Sillanpää、Joan Llibre
    DOI:10.1021/ic980329+
    日期:1998.12.1
    compounds depending on the nature of R and R'. If R = R' = (t)Bu, a closo compound with one vertex occupied by "[Pd(P(t)Bu(3))(2)]" is obtained. When aryl groups are present in the starting phosphine complex, the zwitterionic non-metal-containing compounds are obtained. The crystal structure of one of them has been determined, and the compound has been proven to be 7,8-&mgr;-(S(CH(2))(3))-11-PPh(3)-7,8-C(2)B(9)H(9)
    [C(2)B(9)H(12)](-)的第一个环状单醚衍生物是由1-(SH)-1,2-C(2)B(10)H(11)合成的。后者与(n)BuLi和1,3-二溴丙烷的反应生成1,2-&mgr;-(S(CH(2))(3))-1,2-C(2)B(10)H (10)。部分降解会导致[7,8-&mgr ;-( S(CH(2))(3))-7,8-C(2)B(9)H(10)](-)。[7,8-&mgr ;-( S(CH(2))(3))-7,8-C(2)B(9)H(10)](-)与[PdCl(2)( PRR'(2))(2)]取决于R和R'的性质,会产生不同的化合物。如果R = R’=(t)Bu,则获得一个顶点被“ [Pd(P(t)Bu(3))(2)]占据的closo化合物。当起始膦配合物中存在芳基时,获得两性离子非含属化合物。已确定其中之一的晶体结构,并且该化合物已证明为7,8-&mgr;。-(S(CH(2))(3))-11-PPh(3)-7
  • Synthesis of monosubstituted functional derivatives of carboranes from 1-mercapto-ortho-carborane: 1-HOOC(CH<sub>2</sub>)<sub>n</sub>S-1,2-C<sub>2</sub>B<sub>10</sub>H<sub>11</sub>and [7-HOOC(CH<sub>2</sub>)<sub>n</sub>S-7,8-C<sub>2</sub>B<sub>9</sub>H<sub>11</sub>]<sup>−</sup>(n = 1–4)
    作者:Marina Yu. Stogniy、Igor B. Sivaev、Pavel V. Petrovskii、Vladimir I. Bregadze
    DOI:10.1039/b916022a
    日期:——
    A general approach to synthesis of monosubstituted functional derivatives of 1,2-dicarba-closo-dodecaborane (ortho-carborane) is proposed. Reactions of the triethylammonium salt of 1-mercapto-ortho-carborane (Et3NH)[1-S-1,2-C2B10H11] with ethyl ω-bromoalkyl carboxylates and ω-bromoalkylnitriles in ethanol result in the corresponding carboranyl esters and nitriles that in turn can be converted to carborane-based
    合成单取代的功能衍生物的一般方法 1,2- dicarba-闭合碳-dodecaborane (原碳烷)的提议。的反应三乙1-巯基邻氨基甲酸酯(Et 3 NH)[1-S-1,2-C 2 B 10 H 11 ]与ω-烷基羧酸乙酯和ω-烷基腈的盐乙醇导致在相应的碳硼烷基酯和腈,反过来可以转换为基于碳硼烷羧酸1-HOOC(CH 2)Ñ S-闭合碳-1,2--C 2乙10 ħ 11(Ñ = 1-4)。在轻度脱闭合碳-carborane笼脑脊液 在乙醇中给出 相应的nido -carboranes Cs [7-HOOC(CH 2)n S - nido -7,8 -C 2 B 9 H 11 ]的盐。该方法适用于合成用于 中子俘获疗法和 放射性核素 癌症诊断。
  • Probing the Electronic Structure of Platinum(II) Chromophores:  Crystal Structures, NMR Structures, and Photophysical Properties of Six New Bis- and Di- Phenolate/Thiolate Pt(II)Diimine Chromophores
    作者:Julia A. Weinstein、Mark T. Tierney、E. Stephen Davies、Karel Base、Anthony A. Robeiro、Mark W. Grinstaff
    DOI:10.1021/ic051733t
    日期:2006.5.1
    A general route for synthesis of six structurally similar Pt(II) diimine thiolate/phenolates chromophores possessing bulky phenolate or thiolate ligands is reported. The Pt chromophores were characterized using an array of techniques including 1H, 13C, and 195Pt NMR, absorption, emission, (spectro)electrochemistry, and EPR spectroscopy. Systematic variation of the electronic structure of the Pt(II)
    报道了合成具有大体积盐或硫醇盐配体的六个结构相似的Pt(II)二亚胺硫醇盐/盐生色团的一般路线。使用包括1H,13C和195Pt NMR,吸收,发射,(光谱)电化学和EPR光谱在内的一系列技术对Pt发色团进行了表征。Pt(II)发色团电子结构的系统变化是通过(i)改变溶剂极性来实现的;(ii)用氧取代供体配体中的;(iii)从双配位到双配位交替的供体配体;(iv)改变配体的给电子/吸电子性质。这些新发色团的最低激发态基于吸收和发射光谱UV / vis(从Pt / S(或Pt / O)混合特征的HOMO跃迁到[电荷转移至二亚胺]跃迁。光谱,电化学和EPR光谱。发色团之一Pt(dpphen)(3,5-二叔丁基-邻苯二酚)代表Pt(II)二亚胺盐发色团的一个例子,该发色团具有可逆氧化,主要集中在供体配体上。EPR光谱的结果表明Pt(II)轨道参与了HOMO。与其他混合配体Pt(II)化合
  • Synthesis and in Vitro Studies of a Series of Carborane-Containing Boron Dipyrromethenes (BODIPYs)
    作者:Sunting Xuan、Ning Zhao、Zehua Zhou、Frank R. Fronczek、M. Graça H. Vicente
    DOI:10.1021/acs.jmedchem.5b01783
    日期:2016.3.10
    A series of seven BODIPYs functionalized with ortho-carborane groups at the 8(meso) or 3/5(α) position were synthesized and characterized by NMR, HRMS, HPLC, and in the cases of 2b and 5b, by X-ray analysis. The BODIPYs exhibited low dark toxicity and phototoxicity toward human glioma T98G cells, and their cellular uptake varied significantly, with 5b accumulating the most and 7 the least. All BODIPYs
    合成了7个在8(内消旋)或3/5(α)位置被邻甲戊烷官能团官能化的BODIPY,并通过NMR,HRMS,HPLC进行了表征,在2b和5b的情况下,通过X射线分析对其进行了表征。所述BODIPYs表现出低的暗毒性和光毒性朝向人神经胶质瘤细胞T98G,和它们的细胞摄取显著变化,与图5b积累最为和7最小。所有BODIPY主要位于细胞ER内。作为BBB模型,BODIPYs在人hCMEC / D3脑内皮细胞单层上显示出比荧光素黄更高的渗透率。在该系列中,1b的BBB渗透率最高(P e = 16.4×10–5 cm / s),可能是由于其较低的MW(366 Da)和良好的疏性(log  P = 1.5)的结果。低细胞毒性,两亲性,高含量,高细胞摄取和适度的BBB通透性相结合,使得这些化合物有望成为释放剂用于脑肿瘤的BNCT。
查看更多